I agree that this site is using cookies. You can find further informations here.
X
Bi, Youwei
63  results:
Search for persons X
?
1

Experience Learned and Perspectives on Using Model-Integrat..:

Tsakalozou, Eleftheria ; Fang, Lanyan ; Bi, Youwei...
The AAPS Journal.  26 (2024)  1 - p. , 2024
Link: https://doi.org/10.1208/..
 
?
2

Approval of Mycophenolate Mofetil for Prophylaxis of Organ ..:

Al‐Khouja, Amer ; Chaudhri, Nadia ; Velidedeoglu, Ergun...
Clinical Pharmacology & Therapeutics.  , 2024
Link: https://doi.org/10.1002/..
 
?
3

Model‐Informed Approaches to Support Drug Development for P..:

Pan, Xiaolei ; Wang, Li ; Liu, Jiang...
The Journal of Clinical Pharmacology.  63 (2023)  S2 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
4

How to select the initial dose for a pediatric study?:

Ye, Jingjing ; Bi, Youwei ; Ting, Naitee
Journal of Biopharmaceutical Statistics.  33 (2022)  6 - p. 844-858 , 2022
Link: https://doi.org/10.1080/..
 
?
5

Model‐Informed Approach Supporting Drug Development and Reg..:

Li, Ruo‐Jing ; Ma, Lian ; Li, Fang...
The Journal of Clinical Pharmacology.  62 (2022)  S2 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
6

Model‐Informed Drug Development in Pediatric Dose Selection:

Bi, Youwei ; Liu, Jiang ; Li, Fang...
The Journal of Clinical Pharmacology.  61 (2021)  S1 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
7

Model‐Informed Drug Development Approaches to Assist New Dr..:

Xiong, Ye ; Fan, Jianghong ; Kitabi, Eliford...
Clinical Pharmacology & Therapeutics.  111 (2021)  3 - p. 572-578 , 2021
Link: https://doi.org/10.1002/..
 
?
8

A disease progression model of longitudinal lung function d..:

Bi, Youwei ; Rekić, Dinko ; Paterniti, Miya O....
Journal of Pharmacokinetics and Pharmacodynamics.  48 (2020)  1 - p. 55-67 , 2020
Link: https://doi.org/10.1007/..
 
?
9

Role of Model‐Informed Drug Development in Pediatric Drug D..:

Bi, Youwei ; Liu, Jiang ; Li, Lingjue...
The Journal of Clinical Pharmacology.  59 (2019)  S1 - p. , 2019
Link: https://doi.org/10.1002/..
 
?
10

Model-Informed Drug Development Approach Supporting Approva..:

Bi, Youwei ; Liu, Jiang ; Wang, Jie...
The AAPS Journal.  21 (2019)  5 - p. , 2019
Link: https://doi.org/10.1208/..
 
?
11

Benefit-Risk Summary of Regorafenib for the Treatment of Pa..:

Pelosof, Lorraine ; Lemery, Steven ; Casak, Sandra...
The Oncologist.  23 (2018)  4 - p. 496-500 , 2018
Link: https://doi.org/10.1634/..
 
?
12

Population Pharmacokinetic/Pharmacodynamic Modeling of Depo..:

Bi, Youwei ; Perry, Paul J. ; Ellerby, Michael.
CPT: Pharmacometrics & Systems Pharmacology.  7 (2018)  4 - p. 259-268 , 2018
Link: https://doi.org/10.1002/..
 
?
13

A Whole-Body Physiologically Based Pharmacokinetic Model of..:

Bi, Youwei ; Deng, Jiexin ; Murry, Daryl J..
The AAPS Journal.  18 (2015)  1 - p. 228-238 , 2015
Link: https://doi.org/10.1208/..
 
?
14

β-Cyclodextrin enhanced on-line organic solvent field-ampli..:

Li, Ji ; Bi, Youwei ; Wang, Li...
Journal of Pharmaceutical and Biomedical Analysis.  66 (2012)  - p. 218-224 , 2012
Link: https://doi.org/10.1016/..
 
?
15

FDA Approval Summary: Mobocertinib for Metastatic Non-Small..:

Duke, Elizabeth S ; Stapleford, Liza ; Drezner, Nicole...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898076/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
1-15